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Popular misconceptions, opinions and questions in connection with the BfR 
risk assessment of glyphosate 
 
BfR communication No 013/2016 of 19 May 2016 
 
Various press reports and citizens’ inquiries connected with the risk assessment of glypho-
sate have induced the BfR to comment on some misconceptions frequently put forward in 
public. 
 “The WHO first classified glyphosate as carcinogenic and has now changed its mind.” 
 “There is no agreement among scientists. Therefore, politicians cannot make the deci-
sion.” 
 “The reason for the difference between the BfR and IARC assessments is that the BfR 
relies on industry-sponsored studies.”  
 “A significant increase of tumours caused by glyphosate has been reported in animal 
studies.” 
 “Glyphosate has even been detected in breast milk.” 
 “The glyphosate level in urine is way above the toxicological limit value.” 
 “Glyphosate is even found in beer.” 
 “Why don’t you ban glyphosate?” or “Revoke the approval!” 
 “The experts at BfR are not impartial.” 
 “It was actually the agricultural industry (plant protection product manufacturers) that 
conducted BfR’s risk assessment.” 
 “Does the BfR advocate the renewed approval of glyphosate?” 
 
“The WHO first classified glyphosate as carcinogenic and has now changed its mind.” 
It was not the World Health Organisation (WHO) that classified glyphosate as probably car-
cinogenic but carried out by the International Agency for Research on Cancer (IARC), the 
specialized cancer agency of WHO. Just like BfR and other authorities all over the world, 
another WHO committee responsible for the assessment of pesticides, the Joint FAO/WHO 
Meeting on Pesticide Residues (JMPR), comes to the conclusion that in line with the current 
state of scientific knowledge, no carcinogenic risk or mutagenic changes are to be expected 
via food if glyphosate is used properly and for its intended purpose 
(http://www.who.int/foodsafety/areas_work/chemical-risks/jmpr/en/ ). BfR also assessed 
whether the active substance poses a risk to users, workers, bystanders or local residents 
when used properly. According to its own preamble, the IARC only performed a hazard iden-
tification, which can then be considered by national and international authorities in the course 
of their risk assessments (http://monographs.iarc.fr/ENG/Preamble/CurrentPreamble.pdf). 
This “Hazard identification” - in particular, the IARC classification of substances in terms of 
their carcinogenicity - is the first step of the “risk assessment” process. 
(http://www.who.int/features/qa/87/en/). Only when the hazard and the exposure are set in 
relation to each other can it be assessed whether a health risk exists for humans and how 
great it is. This means that IARC only completed the first step in the process of health risk 
assessment, which, where glyphosate is concerned, was completed by BfR, the European 
assessment authorities and JMPR by obtaining the possible health hazards of expected 
glyphosate contamination from agricultural applications. 
 
“There is no agreement among scientists. Politicians cannot make a decision if it is 
not clear whether glyphosate is carcinogenic or not.” 
The health risk assessment is currently undisputed. Just like BfR, the European Food Safety 
Authority (EFSA) and other authorities all over the world, the WHO committee responsible for 
the assessment of pesticides (JMPR) concludes that in line with the current state of scientific 
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knowledge, no carcinogenic risk is to be expected if glyphosate is used properly and for its 
intended purpose. There are different classifications for different aspects. The IARC and BfR 
have fundamentally different mandates, scientific criteria and approaches. The IARC does 
not conduct risk assessments, it analyses completely different hazards that are not intended 
to constitute a recommendation for any governments or authorities. The hazard-related clas-
sification relates to the potential property of an active substance to cause damage, e.g. “car-
cinogenic” (Category 1), such as alcohol, nicotine, processed meat (sausage) and asbestos, 
or “probably carcinogenic” (Category 2a), such as glyphosate or red meat. Classification of 
this kind does not take into consideration the actual intake quantity of the substance and 
thereby the likelihood of the damage actually occurring. Risk assessment, on the other hand, 
takes into account the quantity of a substance which humans actually ingest under realistic 
conditions. This means that IARC examines whether a substance is fundamentally capable 
of causing cancer, no matter under what conditions, whereas BfR additionally examines 
whether the substance actually does pose a risk if used properly.   
 
Another reason for the differing estimations is that IARC only considers published studies in 
line with its statutes. This means that many studies are ignored, such as those prepared 
within the scope of the EU approval process, which are not published. Consequently, BfR 
was able to include many more recent studies in its report that IARC did not consider accord-
ing to its preamble. Conversely, the BfR report assesses all of the studies to which IARC 
refers.  
 
The fact that comparable authorities all over the world, including EFSA, the US Environmen-
tal Protection Agency (EPA) and JMPR, arrived at a comparable assessment also demon-
strates that the risk assessment conducted by BfR is in line with the current state of scientific 
knowledge.  
 
“The reason for the difference between the BfR and IARC assessments is that BfR re-
lies on industry-sponsored studies.” 
BfR is legally obliged to verify applicants’ documentation. It does not rely on this information, 
but rather conducts its own scientific research. In its report, it meticulously checked and as-
sessed all of the applicants’ legally prescribed studies, as well as all other relevant and avail-
able studies. The IARC bases its results on far fewer sources because it does not include 
any unpublished studies in its assessment according to its preamble. That is why some of 
the comprehensive studies submitted by the applicants were not considered.  
 
The IARC classification is also based on studies which were financed by trade and industry. 
The estimation by IARC that there is “sufficient evidence in animals” to show that glyphosate 
is carcinogenic is based on publications of long-term studies on rodents which were financed 
by trade and industry. They were evaluated by BfR as well as the EPA and JMPR, with the 
result that no carcinogenic risk for humans is to be expected from glyphosate. This means 
that the IARC assessment is also based on industry-sponsored studies. Unlike BfR, howev-
er, the originals of these studies were not available to IARC, which only had indirect access 
to them via another publication.  
 
Contrary to IARC, all of the responsible authorities which had access to the originals of these 
studies came to the conclusion that classification of the hazard potential of glyphosate as 
“probably carcinogenic” cannot be made by scientific means and that no carcinogenic risk is 
to be expected from glyphosate if it is used properly and for its intended purpose. 
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“A significant increase of tumours caused by glyphosate has been reported in animal 
studies.” 
The evaluation of the findings of animal experiments in toxicological studies requires special 
expertise. BfR not only evaluated the experimental studies conducted with rodents with re-
gard to their statistical significance, but also using a weight of evidence approach, which in-
cludes the results of all methods of evaluating the results of animal experiments along with 
other findings. These include a reference to background contamination, historical controls, 
OECD recommendations on limit dosages and various statistical comparisons with reference 
to dose-response relationships, the consistency and reproducibility of effects, the plausibility 
with a mechanism of action and the consideration of uncertainty influences, as intended by 
the OECD, ECHA and EFSA guidelines for the testing of chemicals. In this way, BfR arrived 
at the conclusion that neither the studies on rats nor on mice give any indication of a car-
cinogenic or mutagenic risk of glyphosate. 
 
The experts of the European member states as well as JMPR and the US EPA arrived at the 
conclusion that no biologically relevant increase in tumour incidence with relevance for hu-
mans was to be observed in any of the treated groups of animals in the eleven long-term 
studies on rats and mice that were considered. According to the interpretation of IARC, on 
the other hand, two of the studies are alleged to show statistically significant effects on non-
malignant tumours in the pancreas. IARC also determined a positive trend in the number of 
renal tumours and haemangiosarcomas in two studies on male mice, but not for malignant 
lymphomas. Apart from the fact that the assessment authorities BfR, EFSA and JMPR in-
cluded a larger number of studies in the overall evaluation, they considered the increases of 
individual tumours observed exclusively with very high doses as not relevant to humans with 
regard to expected intake, as they could also be attributable to the influence of a general 
toxicity among the animals. The OECD also deliberately recommended a limit dose of 1000 
mg/kg bw for reasons of animal welfare. 
 
BfR, EFSA and the European member states also evaluate whether the active substance in 
a pesticide can pose a health risk to users, workers, bystanders or local residents if used 
properly. Only when a corresponding risk cannot be scientifically expected can an active 
substance be given further approval by the Commission. This means that the European as-
sessment of the active substance goes even further than the assessment of the WHO/FAO 
committee JMPR. 
 
“Glyphosate has even been detected in breast milk.” 
Some media reported in 2015 that glyphosate had been measured in 16 breast milk sam-
ples. This test was conducted on the basis of a method (ELISA) which is not suited for 
measuring glyphosate in breast milk. Details of how this test was conducted have not been 
published. The glyphosate concentrations in the samples are alleged to have been measured 
between 0.21 and 0.43 nanograms (ng), or 0.00000000021 and 0.00000000043 grams (g), 
per millilitre (ml), which means they were roughly 200 times lower than the quantitation limit 
of 75 ng per ml that the manufacturer of the ELISA test stated to be reliable. In addition to 
this, the alleged findings in breast milk were not confirmed by an independent analysis meth-
od. That is why BfR expressed scientific doubt about the reliability of these results and com-
missioned its own study in order to obtain substantiated and verified results.  
 
BfR commissioned research laboratories renowned throughout Europe with the development 
of two independent analysis methods with high sensitivity, which were then used to examine 
114 breast milk samples from Lower Saxony and Bavaria. This study confirmed that no resi-
dues of the active substance glyphosate which is used in plant protection products can be 
detected in breast milk. 
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http://www.bfr.bund.de/en/press_information/2016/08/bfr_study_confirms__no_glyphosate_d
etectable_in_breast_milk-196578.html  
 
One important reason for the BfR study was that concerned mothers had made inquiries at 
BfR for information about the alleged risk of glyphosate residues in breast milk. Breast milk 
continues to be the most natural and therefore best food for babies. 
 
“The glyphosate level in urine is way above the toxicological limit value.” 
Residues of plant protection products are permitted in food up to a certain maximum limit. 
They can be ingested and degraded up to this guide value without endangering health. The 
residue level permits no conclusions about the toxicity of an active substance. If urine con-
tains residues of undesired substances, this is an indication that the substance was excreted. 
Only when it is known how much of the substance remains in the body can it be established 
whether this is a quantity which could damage health. 
 
If the urine values published to date are calculated back to the daily intake quantity of 
glyphosate, it is shown that a person calculated to have a glyphosate level of roughly 4 ng, or 
0.0000000004 g, per ml of urine has ingested less than a hundredth of the tolerable daily 
intake of 0.5 milligrams (mg) per kilogram (kg) of body weight. These data therefore confirm 
the estimated intake quantities that BfR calculated in the residue assessment within the 
scope of the EU active substance examination, and they give no cause for concern accord-
ing to the latest level of available scientific knowledge. 
 
http://www.bfr.bund.de/en/press_information/2016/11/glyphosate_in_the_urine__even_for_c
hil-
dren__the_detected_values_are_within_the_expected_range__without_any_adverse_health
_effects-197173.html  
 
Comparisons with the guide value for drinking water are confusing and are often quoted in 
the discussion about the health risks posed by substances, even though they are usually 
unscientific. This means that the guide value for plant protection product residues in drinking 
water is not derived from health aspects, but rather is a politically established precautionary 
value that applies to all plant protection products. A health hazard does not therefore auto-
matically exist if the guide value for drinking water has been exceeded. The decisive factor is 
to establish whether the ingested (and not the excreted) quantity of a substance exceeds the 
scientifically calculated guide value. What applies here in principle is that a great many sub-
stances, both desired and undesired, are excreted in urine. This in turn means that glypho-
sate levels in urine are to be expected from a scientific point of view and are not unusual.  
 
“Glyphosate is even found in beer.” 
According to media reports, 14 beer varieties were tested for glyphosate residues at the be-
ginning of 2016. If the (highest) values published in the media are used as the basis for cal-
culation, a person would have to drink 1,000 litres of beer every day to reach the toxicologi-
cal limit value. Residues of the active substances used in plant protection products are per-
mitted in legally acceptable concentrations and are to be expected. Constantly improving, 
ever more sensitive analysis methods result in the ability to detect substances virtually eve-
rywhere in the meantime, even in concentrations as low as one femtogram 
(0.000000000000001 g). The existence of a substance or residues thereof is therefore no 
indication of a health risk. 
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The actual health risk was actually overlooked in the report about glyphosate in beer, namely 
the intake of alcohol. Alcohol is carcinogenic and reprotoxic in much smaller quantities. 
 
 “Why don’t you ban glyphosate?” or “Revoke the approval!” 
BfR does not have the legal remit to decide whether the active substances in plant protection 
products are to be approved or not. This also applies to glyphosate. One of the reasons for 
this is the legally established separation of risk assessment and risk management that ap-
plies in Germany and the European Union (EU). BfR is tasked with the scientific risk as-
sessment of substances. Decisions on approval, authorisation or banning, on the other hand, 
fall into the category of risk management and are therefore made by competent authorities, 
such as the Federal Office of Consumer Protection and Food Safety (BVL) or Federal Minis-
try of Food and Agriculture (BMEL), as well as the national government and European Com-
mission. 
 
“The experts at BfR are not impartial.” 
The impartiality and independence of BfR are anchored in law. BfR was founded on 1 No-
vember 2002 under the direction of Green Party minister Renate Künast in order to conduct 
independent, scientific, non-partisan risk assessments, thus enhancing consumer health pro-
tection. All of the civil servants and salaried employees who work at BfR must comply with 
the legal provisions of the German Civil Service. These include, for example, official regula-
tions on impartiality, effectiveness, professional knowledge and corruption prevention, as 
prescribed by German law and the implementing regulations of the Federal Ministry of the 
Interior (see Federal Civil Service Act, Art. 10 Administrative Law Act and other regulations). 
The main task of BfR is to take up a position on the possible health risks of foods, products 
and chemicals, thus advising the federal ministries in their political decisions. For reasons of 
independence, no funding is raised from trade and industry and BfR has no financial in-
volvement in research projects of this kind. 
 
“It was actually the agricultural industry (plant protection product manufacturers) that 
conducted BfR’s risk assessment.” 
According to the European plant protection product regulation, in order to even have a re-
approval application reviewed, the manufacturers must first submit all legally required docu-
mentation and studies to the responsible authority along with the applicant’s own risk as-
sessment. This was decided by the German Bundestag and European Parliament. The au-
thorising authority in Germany is the Federal Office of Consumer Protection and Food Safety 
(BVL). The commissioned authorities then prepare an independent risk assessment on the 
basis of this documentation and their own research and knowledge. The scientific assess-
ment of risks with regard to human health is a sovereign task which is performed exclusively 
at BfR by the institute’s own staff, i.e. civil servants and salaried employees subject to wage 
and salary negotiations, without any external advice or assistance from the likes of repre-
sentatives of trade and industry, associations or businesses. BfR does not receive funding of 
any kind or form from private institutions, nor does it enter into any cooperation projects with 
them. 
 
BfR is independent and may not accept any financial or other benefits from private institu-
tions such as enterprises, associations or private individuals in connection with its profes-
sional activities. BfR is not tied to any directives issued by the BMEL either where risk as-
sessment and communication are concerned. Consequently, BfR is both politically and eco-
nomically independent and does not represent any political or business interests. Risks are 
assessed solely on the basis of scientific criteria. 
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“Does BfR advocate the renewed approval of glyphosate?” 
BfR is strictly neutral where this is concerned and argues neither for nor against the renewed 
approval of glyphosate or any other pesticide active substances. BfR does not make any 
political or management decisions in accordance with its legal remit. 
 
The health risk assessment of glyphosate conducted by BfR showed that, as far as can be 
established by the current state of scientific knowledge, no carcinogenic risk is to be ex-
pected if the substance is used properly and for its intended purpose. This assessment was 
confirmed by experts in the other EU member states and the European Food Safety Authori-
ty (EFSA), as well as the WHO/FAO committee Joint FAO/WHO Meeting on Pesticide Resi-
dues (JMPR). Irrespective of a science-based health assessment, the EU Commission can 
decide against the approval of a substance for other reasons, such as ethical or political res-
ervations, but this does not affect the impartiality and professional objectivity of the BfR risk 
assessment. 
